Jørgen Hilden
Lektor emeritus
1 - 2 ud af 2Pr. side: 500
- 2013
- Udgivet
Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial
Harutyunyan, M., Goetze, Jens P. , Winkel, P., Johansen, Julia Sidenius, Hansen, J. F., Jensen, G. B., Hilden, Jørgen, Kjøller, E., Kolmos, H. J., Gluud, C. & Kastrup, J., jul. 2013, I: Immunobiology. 218, 7, s. 945-51 7 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
- Udgivet
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors
Hróbjartsson, A., Thomsen, A. S. S., Emanuelsson, F., Tendal, B., Hilden, Jørgen, Boutron, I., Ravaud, P. & Brorson, Stig, 5 mar. 2013, I: C M A J. 185, 4, s. E201-11Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
ID: 314941
Flest downloads
-
172
downloads
Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Udgivet -
160
downloads
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
149
downloads
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet